Clinical Trial

Computed Tomography Coronary Angiography (CTCA) Prognostic Registry for Coronary Artery Disease

Study acronym: PRORECAD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 13, 2021 (before its estimated September 2022 completion). Its status may not reflect the trial's current state.
Summary
The study aims at pooling a large population of patients with suspected coronary artery disease (CAD) who underwent Computed Tomography Coronary Angiography (CTCA) and who were adequately stratified in the first place. Then the investigators will be able to assess the incremental value of CTCA in the stratification of prevalence of disease (non obstructive/obstructive) and prognosis of patients with suspected CAD). The added information to current evidence is how reliable and to what extent CTCA can define the actual burden of disease and cardiovascular risk.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2011-06-28; most recent amendment 2021-01-12.
Trial Details
NCT Number NCT01384721
Lead Sponsor Azienda Ospedaliero-Universitaria di Parma
Collaborators: Società Italiana di Radiologia Medica
Conditions Coronary Artery Disease, Atherosclerosis
Enrollment 1,000 participants
Start Date 2010-09
Primary Completion 2022-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2021-01-13